Methotrexate in psoriatic arthritis: a retrospective study
DOI:
https://doi.org/10.2340/0001555563165167Abstract
The response of psoriatic arthritis to methotrexate was evaluated retrospectively in 59 consecutive patients. Initially almost all received 15 mg weekly. When clinical improvement occurred, the dose was gradually reduced. In 7 patients methotrexate had to be discontinued within a year due to adverse reactions. The remaining 52 patients were treated from 1 to 11 years, median 3 years. Among these a modest improvement was seen in 21, while in 22 the signs of inflammatory joint disease almost disappeared. The favourable response was related to the short duration of arthritis, but unrelated to the severity of the disease.Downloads
Download data is not yet available.
Downloads
Published
1983-03-01
How to Cite
Kragballe, K., Zachariae, E., & Zachariae, H. (1983). Methotrexate in psoriatic arthritis: a retrospective study. Acta Dermato-Venereologica, 63(2), 165–167. https://doi.org/10.2340/0001555563165167
Issue
Section
Articles
License
LicenseAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
